Gene · 241
Papers2,196
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,196
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. | Genes (Basel) | 2022 | 36011386 | PubTator, text mining | PubMed |
| The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. | Signal Transduct Target Ther | 2022 | 36008393 | PubTator, text mining | PubMed |
| Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade. | Med | 2022 | 36007524 | PubTator, text mining | PubMed |
| Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion. | Front Oncol | 2022 | 35978827 | PubTator, text mining | PubMed |
| Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review. | Front Oncol | 2022 | 35928873 | PubTator, text mining | PubMed |
| Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis. | Clin Exp Gastroenterol | 2022 | 35928254 | PubTator, text mining | PubMed |
| Network Pharmacology Integrated Molecular Docking to Explore the Mechanism of Blister Beetle Therapy for Lung Adenocarcinoma. | Contrast Media Mol Imaging | 2022 | 35909589 | PubTator, text mining | PubMed |
| Introducing the "Twilight" operating room concept: a feasibility study to improve operating room utilization. | Patient Saf Surg | 2022 | 35897019 | PubTator, text mining | PubMed |
| The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis. | Genes (Basel) | 2022 | 35893056 | PubTator, text mining | PubMed |
| Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis. | J Pers Med | 2022 | 35887565 | PubTator, text mining | PubMed |
| MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential. | Diagnostics (Basel) | 2022 | 35885514 | PubTator, text mining | PubMed |
| Cyclic Hypoxia Induces Transcriptomic Changes in Mast Cells Leading to a Hyperresponsive Phenotype after FcεRI Cross-Linking. | Cells | 2022 | 35883682 | PubTator, text mining | PubMed |
| Identification of TLR2 as a Key Target in Neuroinflammation in Vascular Dementia. | Front Genet | 2022 | 35873459 | PubTator, text mining | PubMed |
| Helical remodeling augments 5-lipoxygenase activity in the synthesis of proinflammatory mediators. | J Biol Chem | 2022 | 35863431 | PubTator, text mining | PubMed |
| Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment. | Front Immunol | 2022 | 35860256 | PubTator, text mining | PubMed |
| Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design, Volume II. | Front Pharmacol | 2022 | 35847004 | PubTator, text mining | PubMed |
| Exploration of Shared Gene Signatures and Molecular Mechanisms Between Periodontitis and Nonalcoholic Fatty Liver Disease. | Front Genet | 2022 | 35836570 | PubTator, text mining | PubMed |
| Outcomes Associated with Nasal Reconstruction Post-Rhinectomy: A Narrative Review. | Arch Plast Surg | 2022 | 35832679 | PubTator, text mining | PubMed |
| An In Vivo Model of Human Macrophages in Metastatic Melanoma. | J Immunol | 2022 | 35817516 | PubTator, text mining | PubMed |
| Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process. | Molecules | 2022 | 35807415 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/241/papers?page=18